Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Frank Buck who wrote (574)	11/24/1997 5:30:00 PM
From: george	Read Replies (1) \| Respond to of 1894

Frank and Cisco, Thanks for the postings...... 50% growth sounds ok to me.... Today I talked to another path lab....they knew about thin prep slides and about neopath for secondary screening if the patient wants it, but it costs extra and not many patients elect to request them...they said their biggest problem was a shortage of cytologists....and they are sensitive about the legal liabilites and that pap smears are loss leaders...also, she did not know about Accumed...it will take time to get the word out. George